Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Brachytherapy|August 22, 2025
Intraoperative low-dose rate brachytherapy as an adjunct to surgery for marginally resectable rectal and recurrent anorectal carcinomasMustafa M Al Balushi, Teresia M Perkins, Kee-Young Shin, et al.
Advances in Radiation Oncology|March 10, 2023
Spinal Cord Delineation Based on Computed Tomography Myelogram Versus T2 Magnetic Resonance Imaging in Spinal Stereotactic Body Radiation TherapyLubna Hammoudeh, Abdullah M Abunimer, Ho Young Lee, et al.
Clinical Genitourinary Cancer|April 9, 2026
Radiation and Avelumab in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder CancerKent W Mouw, Kee-Young Shin, James Parisi, et al.
Advances in Radiation Oncology|February 26, 2024
A Prospective Study Assessing the Efficacy and Toxicity of Stereotactic Body Radiation Therapy for Oligometastatic Bone MetastasesJoyce H Lee, Diana D Shi, Kee-Young Shin, et al.
Neuro-Oncology|November 19, 2022
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticityJamie A Dean, Shyam K Tanguturi, Daniel Cagney, et al.
Advances in Radiation Oncology|June 23, 2025
Spinal Instability Neoplastic Score as a Predictor of Vertebral Fracture in Patients Undergoing Radiation Therapy for Spinal Metastases: A Single-Institution StudyPatrick Doyle, Sarah Caplan, Neil Klinger, et al.
The Journal of Clinical Investigation|March 17, 2025
Epigenetic therapy sensitizes anti-PD-1 refractory head and neck cancers to immunotherapy rechallengeTingting Qin, Austin K Mattox, Jean S Campbell, et al.
Neuro-Oncology Advances|August 9, 2023
Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppressionDavy Deng, Lubna Hammoudeh, Gilbert Youssef, et al.
Radiology|October 29, 2024
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate CancerDavid D Yang, Leslie K Lee, James M G Tsui, et al.
JAMA Oncology|October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical TrialKartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.
Pageof 3